Introduction
The intestinal tract is an important bacterial reservoir and source for transmission of hospitalacquired infections. [1] . The intestinal tract contains 300-500 different species of bacteria that are most abundant in the large intestine and rectum. The faecal mass contains up to10 11-10 12 living bacteria per gram and about 60% of its weight consists of bacteria [2] [3] [4] . This provides a complex and dynamic ecosystem of living bacteria, which contributes to energy harvest from food, and plays an important role in the maturation of the human immune system. Intra-abdominal infections are often of poly-microbial origin were Escherichia coli and other species of Enterobacteriaceae dominates followed by enterococci [5, 6] . Other important pathogens are staphylococci, yeasts and anaerobic bacteria. When a patient is treated with systemic antibiotics the resident bowel flora will also be unduly influenced. Broad-spectrum antibiotic treatment disturbs the balance between different bacterial species in the bowel and increases the incidence of antibiotic resistant Enterobacteriaceae [7, 8] . The aim of the present open observational study was to investigate changes in the rectal flora and the emergence of antibiotic resistance in Enterobacteriaceae and non-fermentative gramnegative bacteria, among patients with intra-abdominal infection receiving antibiotics.
Materials and methods

Study population
Inclusion criteria were adult patient, age over eighteen years, admitted to a surgical ward having a suspected diagnosis of complicated intra-abdominal infections requiring surgical intervention with the following criteria: 1) Cholecystitis (including gangrenous) and either rupture, perforation or progression of the infection beyond the gallbladder wall. Surgical Traumatic perforation of the intestines, only if operated on >12 hours after perforation occurs. 6) Peritonitis due to perforated viscus, or other focus of infection (but not spontaneous bacterial peritonitis associated with cirrhosis and chronic ascites). 7) Intra-abdominal abscess including of liver and spleen abscesses. Alternatively patients with suspicion of any above-mentioned diagnoses were the surgeons chose non-surgical treatment with antibiotic treatment with or without percutaneous intra-abdominal drainage. In the later group we intended to include patients with at least 5 days of antibiotic treatment if there was no surgical intervention, but since there was an intension to treat design we also decided to include patients with shorter treatment.
Participating units were surgical units in eight hospitals from the mid and southern parts of Data registered for the study included age, gender, inclusion diagnosis, surgical interventions, discharge diagnosis, co-morbidity (malignancy, chronic obstructive pulmonary disease, and diabetes mellitus), previous antibiotics and travel outside Sweden during the last 6 months were recorded. Antibiotic treatments were introduced according to local guidelines and traditions, and were chosen by the attending physician,
Bacterial and yeast cultures
To get samples before antibiotic treatment of a patient with an acute need of antibiotic treatment we had to choose rectal swabs in favour of faecal samples of practical reasons and there was not time waiting for defecation before antibiotic treatment. The sample after antibiotic treatment was obtained in the same way as the pre-exposure sample. Rectal swabs were obtained on admission (Sample 1) and 2-14 days after the end of antibiotic treatment (Sample 2). Rayon swabs with transport medium (Copan, Brescia, Italy) were used. All samples were sent to the Clinical Microbiology Research Laboratory, Linköping University. At the laboratory the swabs was directly put down into 1.0 ml of freeze broth (Nutrient broth, No 2, Lab m Bury, United Kingdom, containing glycerol 15%) in a sterile glass tube and shaken thoroughly. The freeze broth was transferred to a plastic storage tube.
The rayon swab tip was cut off directly down into the freeze broth in the storage tube and stored at -70°C until analysis. When analysing the samples, they were thawed and once again shaken. The original rayon swab was handled with sterile technique and stroked with a primary streak on one chromogenic UTI-agar plate (Oxoid, Basingstoke, United Kingdom) and stroked over a second UTI-agar plate using a dish rotator (Bio-Merieux, Marcy l'Etoile, France). Chromogenic UTI medium (Oxoid, Basingstoke, United Kingdom) is a chromogenic agar plate that eases the identification of uropahtogenes like Enterobacteriaceae, enterococci and staphylococci by different coloration of colonies useful in mixed cultures [9] .
To facilitate identification of different species, antibiotic discs (ampicillin aztreonam, ceftazidime, cefotaxime and linezolid; Oxoid, Basingstoke, United Kingdom) were placed on one of the plates. The agar plates were incubated overnight at 35°C. Different bacterial colonies were identified visually and bacterial isolates considered to be different species or subspecies found, were identified to species or family level using standard biochemical methods [10] . The dominant bacterial population and also subpopulations of Enterobacteriaceae and nonfermentative gram-negative rods were tested for antibiotic susceptibility. Each species was counted once only per patient and sample when measuring distribution of species.
In order to detect emergence of resistance, we analysed more than one isolate per species from each patient. We measured the occurrence of decreased susceptibility in all of the isolates for each species and patient.
Detection of extended-spectrum-betalactamase (ESBL)
Isolates of Enterobacteriaceae with decreased susceptibility to cefotaxime or/and ceftazidime were suspected producers of ESBL. Phenotypic double-strip Etest (AB Biodisk, Solna, Sweden) with cefotaxime with and without clavulanic acid, ceftazidime with and without clavulanic acid or cefepime with and without clavulanic acid were used to confirm classical ESBL-enzymes such as CTX-M, TEM and SHV designated ESBL A . Etest with cefotetan with or without cloxacillin were used to confirm plasmid AmpC, designated ESBL M . When the minimum inhibitory concentration (MIC) ratio of cephalosporin/cephalosporin with clavulanic acid ≥8 or a phantom/deformation zone occurred, an ESBL-fenotype was considered. When the minimum inhibitory concentration (MIC) ratio of cefotetan/cefotetan with cloxacillin ≥8 or a phantom/deformation zone occurred, an AmpCL-fenotype was considered. Klebsiella pneumoniae isolates with phenotypic AmpC were considered to have a plasmid AmpC genotype. Isolates with ESBL A -phenotype were genetically confirmed using PCR as described earlier [11] to detect enzymes of CTX-M, and SHV and TEM genotype. E. coli isolates with AmpC phenotype were genetically confirmed by multiplex PCR according to Perez and Hanson [12] to verify plasmid mediated AmpC.
Statistical analysis
In the colonisation analysis the material was summarised as indicator variables. The indicator variables were presence or absence of each particular species; quantity was not taken into consideration. The gain or loss of a bacterial species was compared between Samples 1 and 2 using McNemars test. The total number of species present was tested with pair-wise student's t-test.
The fact that all species were not found in each sample made it difficult to evaluate emergence of resistance in each species, hence we divided the material into a group with Enterobacteriaceae (EBC) and non-fermentative gram negative bacteria (NF).
The EBC group included all Enterobacteriaceae species and the NF group included P aeruginosa, Pseudomonas spp (Pseudomonas non P aeruginosa), and Acinetobacter spp.
Each combination of antibiotic and group were analysed separately. The fraction of Enterobacteriaceae with decreased susceptibility in Samples 1 and 2 from each patient was calculated. The fraction of non-fermentative with decreased susceptibility in Samples 1 and 2 was calculated for each patient. The fraction of decreased susceptibility was defined as the number of species with decreased susceptibility divided by the number of species found.
Finally the mean fractions of species with decreased susceptibility in the study population were compared between Samples 1 and 2 with two-way analysis of variance with time as fixed factor and patient as random factor. P values <0.05 were considered significant.
Results
Population
One hundred ninety seven patients were initially included. Fifty five patients were subsequently excluded due to failure of sampling, and 2 patients were excluded due to missing demographic data. Thus, samples from 140 patients (70 women and 70 men) were investigated in the final analyses. Surgery was performed in 83 patients (59.2%) the most common procedure being appendectomy (44; 31.4%) followed by colectomy and cholecystectomy (13; 9.3% respectively). Fifty seven (40.7 %) patients were not operated upon.
Eighty two (59%) patients had a concomitant diagnosis. Diagnoses were dominated by hypertension 34 patients (24%), followed by diabetes 11 patients (8%), malignancy 6 patients (4%), asthma 6 patients (4%), chronic arthritic disease 5 patients (4%) and chronic obstructive pulmonary disease 4 patients (3%). Twenty seven patients (19%) had received antibiotic treatment within six months preceding inclusion, and 34 patients (24%) had travelled outside Sweden. Data was missing for 8 patients regarding previous travel and antibiotic treatment. (Table I) .
Antibiotic treatment
Treatments in the carbapenem group included imipenem, meropenem and ertapenem. 
Microorganisms isolated
The three most common aerobic bacteria isolated in Sample 1 were E coli (90.0% of all patients) followed by E. faecalis (57.9%) and yeast (31.7%). In Sample 2 yeast was the most common isolate (70.7% of the patients), followed by E faecalis (64.3%) and E coli (57.9 %.)
Other differences observed between Samples 1 and 2 were a decrease in P aeruginosa (16.4% in Sample 1 and 5.7% in Sample 2), an increase in E faecium (21.4 and 50.0%, respectively) and Enterobacteriaceae not further typed (3.6 and 10.7%, respectively). (Table II) There was thus, a significant loss of E coli and P aeruginosa and a significant gain in E faecium and yeasts between Samples 1 and 2. The group of Enterobacteriaceae, which were not identified further with routine laboratory tests also gained in numbers. (Figure 2 )
Antibiotic resistance
The mean fraction of Enterobacteriaceae with decreased susceptibility to cefotaxime per patient, increased from 0.357 before antibiotic treatment to 0.507 after antibiotic treatment.
The corresponding figures for cefuroxime and piperacillin-tazobactam were an increase from 0.600 to 0.800 and from 0.307 to 0.450 respectively. There were no differences in the mean fraction of Enterobacteriacae with decreased susceptibility to ciprofloxacin, gentamicin, imipenem and trimethoprim-sulphamethoxazole, per patient, before and after antibiotic treatment.
In the group of non-fermentative gram-negative rods the mean fraction of decreased susceptibility to antibiotic, per patient, decreased for imipenem from 0.043 to 0.007. In this group there were no significant differences in antibiotic susceptibility per patient, before and after antibiotic treatment, to ceftazidime and ciprofloxacin. (Table III) Two (1.4%) patients had ESBL-producing E coli in Samples 1 and 2. One (0.7%) patient had ESBL-producing E coli in Sample 1 only and one (0.7%) patient in Sample 2 only. ESBLenzymes found were CTX-M 15/28, CTX-M 14 analogous and CTX-M 3/22. Other enzymes found were TEM-1, TEM-2 and SHV-1 alike. Four (2.8%) patients had Klebsiella pneumoniae isolates with plasmid Amp-C before antibiotic treatment and two (1.4%) still had these after antibiotic treatment. No other ESBL-producing Enterobacteriaceae was found.
Discussion
The main finding of this study on patients with severe intra-abdominal infections was a shift in faecal floral pattern from E.coli to other Enterobacteriacae, E.faecium and yeasts following antibiotic treatment. The fraction of decreased susceptibility to cephalosporins and piperacillin-tazobactam in Enterobacteriaceae increased after antibiotic treatment. The loss of E coli and gain of other Enterobacteriaceae, the shift from E faecalis to E faecium was mainly a shift to species with more intrinsic antibiotic resistance. Consequently this indicates that emerge of resistance is not due to mutations but selection of more resistant species.
Most studies on the effect of antibiotic treatment on bowel flora have been performed in healthy humans. [13] Most of the antibiotics used for treatment in this study are mainly eliminated via the urinary tract, and the amount of antibiotics found in faeces is often low (approximately 1-5%) [14] [15] [16] [17] [18] [19] . An exception to this in our study is ertapenem where about 10% of the dose is found in the faeces [20] . This study wasn't powered to compare different treatment groups, effect on the faecal flora.
The strength of this study was that we investigated samples from patients treated for acute intra-abdominal infection in a clinical setting, thus hopefully reflecting clinical reality. There are few other studies where the whole potential pathogenic aerobic fecal flora has been examined after antibiotic therapy. In multicentre studies similar to ours, a substantial increase in bowel colonisation with resistant Enterobacteriaceae in patients treated with piperacillintazobactam or ceftriaxone in combination with metronidazol was shown, which is in agreement with our findings [8] .
The practical choice of rectal swabs in favor of fecal samples may affect the amount of species that we were able to identify, due to the volume of the sample; this is a weakness of the study design. Since we used rectal swabs on all samples the differences we were able to show was actually differences in the flora. Another limitation of this study is that it was not designed or empowered to evaluate risk factors for acquiring antibiotic resistant Enterobacteriaceae with different antibiotic regiments. Furthermore, we did not analyse to see if there was a correlation between fecal colonisation and infection.
The antibiotic treatments applied were very disparate, due to the observational design, and it was not possible to evaluate each treatment strategy separately. This reflects the clinical settings diversity of antibiotic treatment and treatment length. A predetermined antibiotic treatment protocol with different treatment groups would make it possible to perform such an evaluation.
In our study we observed changes in the faecal flora and the emergence of Enterobacteriaceae with decreased susceptibility to cephalosporins and piperacillinetazobactam but not carbapenems, after antibiotic treatment. However, this study was not designed to determine if the changes in the faecal flora were caused by antibiotic treatment, the surgical intervention itself or cross transmission.
Pena et al has showed that carriage of Klebsiella pneumoniae-ESBL in the digestive tract is an independent variable associated with infection with the same K pneumoniae-ESBL, and the faecal carriage occurred 2-90 days prior of infection [21] Ben-Ami et al has shown that patients with ESBL-producing Enterobacteriaceae in faecal samples, at admission to a tertiary hospital in Tel Aviv, has grater risk of septicaemia with Ceftazidime-resistant isolate of the same species up to three month after admission (OR, 38.9;p<0,001). [22] These data suggests that Enterobacteriaceae in the rectal flora can cause infections in the host.
In conclusion, our results indicate that antibiotic treatment alters the distribution of species in the aerobic potential pathogenic faecal flora and increases the fraction of Enterobacteriaceae with decreased susceptibility to cephalosporins and piperacillintazobactam. These changes should be taken into consideration in patients with severe intraabdominal infections when initial treatment fails and further antibiotic treatment is required. Gram-negative bacteria not Enterobacteriaceae.
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